semaglutide weight loss philadelphia Microdosing Ozempic Semaglutide For Weight Loss Compared
Description
doi: 10.1016/j.hsr.2022.100032
A trial of more than 17,000 people found semaglutide (the active drug in Ozempic/Wegovy) cut the risk of serious heart attacks and strokes by 20%, even in people without diabetes
When used together, their effects are additive, meaning they work together to lower blood sugar more than either would alone
Chew thoroughly and slowly
patients to speak with their healthcare providers for an accurate risk assessment
